Bharat Biotech says typhoid vaccine shown to be safe, effective in human trialsPost published:October 2, 2017Post category:Industry NewsClinical studies showed 87% effectiveness for Typbar-TCV typhoid vaccine, says Bharat Biotech Source: Livemint.com (http://www.livemint.com/rss/industry)Read more articles Previous PostMeet the Man Who Designed Your iPhone (It Wasn’t All Steve Jobs) Next PostD-Mart’s rising brand value shows that hyperlocal pays You Might Also Like TT Electronics announces acquisition of Precision June 5, 2018 Creating 120 million jobs by 2020 will be difficult: TeamLease report July 5, 2017 Beckhoff releases EL3783 EtherCAT Terminal for power monitoring February 9, 2018